Anales de la Facultad de Medicina
Universidad Nacional Mayor de San Marcos
Copyright© 2000

ISSN 1025 - 5583
Vol. 62, Nº1 - 2001


BIBLIOGRAFÍA


1) Cohen P, Schneiderman P. Clinical manifestations of the Marfan’s Syndrome. Inter J Dermatol 1989; 28(5):291-9.

2) Bruno L, Tredici S, Mangiavacchi, Colombo V, Mazzotta G, Sirtori C. Cardiac, skeletal, and ocular abnormalities in patients with Marfan’s Syndrome and in their relatives. Br Heart J 1984; 51:220-30.

3) Pyeritz R. Genetics and cardiovascular disease. En: Braunwald. Heart Disease 5th Edition 1997; 2:1650-86.

4) Kodolitsch Y, Raghunath M, Nienaber A. Das Marfan-Syndrom. Dtsch Med Waschz 1998; 123:21-5.

5) Maron B, Moller J, Seldman CH, Vincent G, Dietz H, Moss A, y col. Impact of laboratory molecular diagnosis on contemporary diagnostic criteria for genetically transmitted cardiovascular diseases: hypertrophic cardiomyopathy, long-QT Syndrome, and Marfan’s Syndrome. Circulation 1998; 98:1460-71.

6) Adams J, Trent R. Aortic complications of Marfan’s syndrome. Lancet 1998; 352:1722-3.

7) Eaton L, Meiner S. Marfan’ syndrome: Identification and management. Medsurg Nursing 1999; 8(2): 113-8.

8) Gambirazio K. Aracnodactilia. Tesis de Bachiller en Medicina. UPCH. 1987.

9) Doroshow R, Lin H, Milliken J. Infantile Marfan’s Syndrome. Circulation 1998; 97: 1103-4.

10) Roman M, Devereux R, Kramer-Fox R, Spitzer M. Comparison of cardiovascular and skeletal features of primary mitral valve prolapse and Marfan’s Syndrome. Am J Cardiol 1989; 63: 317-21.

11) Haouzi A, Benglund H, Pelikan P, Maurer G, Siegel R. Heterogeneous aortic response to acute beta-adrenergic blockade in Marfan’s Syndrome. Am Heart J 1997; 133(1): 60-3.

12) Chan K, Callahan J, Seward J, Takik J. Marfan’s Syndrome diagnosed in patients 32 years of age or older. Mayo Clin Proc 1987; 62: 589-94.

13) Silverman D, Burton K, Gray J, Bosner M, Kouchdukos N, Roman N, y col. Life expectancy in the Marfan Syndrome. Am J Cardiol 1995; 75:157-60.

14) Salim M, Albert B, Ward J, Pyeritz R. Effect of beta-adrenergic blockade on aortic root of dilatation in the Marfan Syndrome. Am J Cardiol 1994; 74: 629-33.

15) Devereux R, Roman M. Aortic disease in Marfan’s syndrome. N Engl J Med 1999; 340(17): 1358-9.

16) Gott V, Greene P, Alejo D, Cameron D, Naftel D, Miller C, y col. Replacement of the aortic root in patients with Marfan’s syndrome. N Engl J Med 1999; 340(17): 1307-13.

REGRESAR AL ARTÍCULO